INVIVO CLINICAL LIMITED
Get an alert when INVIVO CLINICAL LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2027-03-31 (in 10mo)
Last filed for 2025-06-30
Confirmation statement due
2027-03-14 (in 10mo)
Last made up 2026-02-28
Watchouts
None on the register
Cash
£129K
lowest in 6 filed years
Net assets
-£337K
lowest in 6 filed years
Employees
40
highest in 6 filed years
Profit before tax
-£894K
Period ending 2025-06-30
Net assets
6-year trend · vs Health Care median
Accounts
6-year trend · latest reflected 2025-06-30
| Metric | Trend | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2023-12-04 | 2024-06-30 | 2025-06-30 |
|---|---|---|---|---|---|---|---|
| Turnover | — | — | — | — | £2,559,169 | £4,792,171 | |
| Operating profit | — | — | — | — | -£319,346 | -£887,890 | |
| Profit before tax | — | — | — | — | -£328,075 | -£893,976 | |
| Net profit | — | — | — | — | -£328,075 | -£757,366 | |
| Cash | £534,948 | £588,428 | £703,293 | £464,182 | £644,698 | £128,980 | |
| Total assets less current liabilities | £893,764 | £1,065,219 | £989,210 | £675,257 | £660,223 | -£115,077 | |
| Net assets | £490,685 | £691,147 | £742,329 | £538,086 | £420,784 | -£336,582 | |
| Equity | £490,685 | £691,147 | £742,329 | £538,086 | £420,784 | -£336,582 | |
| Average employees | 26 | 31 | 30 | 34 | 35 | 40 | |
| Wages | — | — | — | — | £777,604 | £1,693,404 | |
| Directors' remuneration | — | — | — | — | £36,073 | £41,364 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Year-on-year
FY2024 → FY2025 · period ending 2025-06-30 vs 2024-06-30
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2023-12-04 | 2024-06-30 | 2025-06-30 |
|---|---|---|---|---|---|---|---|
| Operating margin | — | — | — | — | -12.5% | -18.5% | |
| Net margin | — | — | — | — | -12.8% | -15.8% | |
| Return on capital employed | — | — | — | — | -48.4% | 771.6% | |
| Current ratio | — | — | — | — | 1.16x | 0.75x | |
| Interest cover | — | — | — | — | -27.25x | -92.81x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 1 time since incorporation
- INVIVO CLINICAL LIMITED 2013-02-26 → present
- NUTRITION GEEKS LIMITED 2007-03-27 → 2013-02-26
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- MHA
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“In addition, the Directors have received a Letter of Financial Support from Microba Life Sciences Ltd dated 11th March 2026, confirming the parent's intention to provide financial support for a period of 13 months from that date, covering working capital requirements, trade creditors, operating expenses and any other obligations necessary to sustain ongoing business activities. Whilst this letter constitutes a statement of intent rather than a legally binding commitment, the Directors have taken comfort from this confirmation in concluding that the going concern basis of preparation remains appropriate.”
Significant events
- “Since the balance sheet date, the company has undertaken a strategic review of its operations to support future growth plans. As part of this process, certain product lines have been retired to allow for a greater focus on key areas of expansion. Additionally, operational restructuring has resulted in changes to facility usage, including the closure of specific sites, with a number of roles put at risk of redundancy. These steps align with the company's long-term strategy to enhance efficiency and drive innovation in priority areas and were completed at the time of filing these accounts.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 10 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| BUCHER, Michael Max | Director | 2023-12-05 | Jul 1973 | Swiss |
| MAREE, Don Wessel | Director | 2024-04-08 | Jul 1977 | British |
| REID, Luke Holtham | Director | 2023-12-05 | Jun 1988 | Australian |
Show 10 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| NORTHSIDE COMPANY SECRETARIAL SERVICES LTD | Corporate Secretary | 2007-03-27 | 2008-11-13 |
| BACCHUS, Humphrey | Director | 2017-04-05 | 2022-11-17 |
| BAIRD, Jamie Summers | Director | 2007-03-27 | 2008-06-24 |
| INGRAM, Faye Louise | Director | 2023-12-05 | 2025-02-28 |
| INGRAM, Faye Louise | Director | 2020-09-14 | 2022-04-25 |
| JOYCE, Louise Lynette | Director | 2020-09-14 | 2022-11-03 |
| MAREE, Don Wessel | Director | 2008-06-14 | 2024-04-08 |
| MAREE, Don Wessel | Director | 2007-03-27 | 2008-06-24 |
| PANCZAK, Eric John | Director | 2017-12-05 | 2021-10-12 |
| RICHARDS, Nicholas Kerry | Director | 2017-12-05 | 2024-12-04 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Microba Uk Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2023-12-05 | Active |
| Don Maree | Individual | Shares 75–100%, Voting 75–100% | 2016-04-06 | Ceased 2023-12-05 |
Filing timeline
Last 20 of 115 total filings
Material constitutional events — rename, articles re-file, resolution
- 2024-01-23 MA Memorandum articles
- 2024-01-23 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-04-10 | AA | accounts | Accounts with accounts type full | |
| 2026-03-17 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-07-17 | AA | accounts | Accounts with accounts type full | |
| 2025-03-14 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-03-06 | TM01 | officers | Termination director company with name termination date | |
| 2025-01-06 | TM01 | officers | Termination director company with name termination date | |
| 2024-09-17 | AA | accounts | Accounts with accounts type total exemption full | |
| 2024-06-21 | AA01 | accounts | Change account reference date company current shortened | |
| 2024-06-20 | AA01 | accounts | Change account reference date company previous shortened | |
| 2024-04-08 | AP01 | officers | Appoint person director company with name date | |
| 2024-04-08 | TM01 | officers | Termination director company with name termination date | |
| 2024-03-05 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-03-01 | AP01 | officers | Appoint person director company with name date | |
| 2024-01-25 | CH01 | officers | Change person director company | |
| 2024-01-23 | MA | incorporation | Memorandum articles | |
| 2024-01-23 | RESOLUTIONS | resolution | Resolution | |
| 2024-01-19 | RP04SH01 | capital | Second filing capital allotment shares | |
| 2024-01-18 | AP01 | officers | Appoint person director company with name date | |
| 2024-01-18 | AP01 | officers | Appoint person director company with name date | |
| 2024-01-17 | AA01 | accounts | Change account reference date company current extended |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 3
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.